BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 31151137)

  • 1. Suppression of Aiolos and Ikaros expression by lenalidomide reduces human ILC3-ILC1/NK cell transdifferentiation.
    Mazzurana L; Forkel M; Rao A; Van Acker A; Kokkinou E; Ichiya T; Almer S; Höög C; Friberg D; Mjösberg J
    Eur J Immunol; 2019 Sep; 49(9):1344-1355. PubMed ID: 31151137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues.
    Cella M; Gamini R; Sécca C; Collins PL; Zhao S; Peng V; Robinette ML; Schettini J; Zaitsev K; Gordon W; Bando JK; Yomogida K; Cortez V; Fronick C; Fulton R; Lin LL; Gilfillan S; Flavell RA; Shan L; Artyomov MN; Bowman M; Oltz EM; Jelinsky SA; Colonna M
    Nat Immunol; 2019 Aug; 20(8):980-991. PubMed ID: 31209406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria.
    Bernink JH; Krabbendam L; Germar K; de Jong E; Gronke K; Kofoed-Nielsen M; Munneke JM; Hazenberg MD; Villaudy J; Buskens CJ; Bemelman WA; Diefenbach A; Blom B; Spits H
    Immunity; 2015 Jul; 43(1):146-60. PubMed ID: 26187413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1β inhibits ILC3 while favoring NK-cell maturation of umbilical cord blood CD34(+) precursors.
    Ambrosini P; Loiacono F; Conte R; Moretta L; Vitale C; Mingari MC
    Eur J Immunol; 2015 Jul; 45(7):2061-71. PubMed ID: 25847448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IKAROS and AIOLOS directly regulate AP-1 transcriptional complexes and are essential for NK cell development.
    Goh W; Sudholz H; Foroutan M; Scheer S; Pfefferle A; Delconte RB; Meng X; Shen Z; Hennessey R; Kong IY; Schuster IS; Andoniou CE; Davis MJ; Hediyeh-Zadeh S; Souza-Fonseca-Guimaraes F; Parish IA; Beavis P; Thiele D; Chopin M; Degli-Esposti MA; Cursons J; Kallies A; Rautela J; Nutt SL; Huntington ND
    Nat Immunol; 2024 Feb; 25(2):240-255. PubMed ID: 38182668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues.
    Bernink JH; Peters CP; Munneke M; te Velde AA; Meijer SL; Weijer K; Hreggvidsdottir HS; Heinsbroek SE; Legrand N; Buskens CJ; Bemelman WA; Mjösberg JM; Spits H
    Nat Immunol; 2013 Mar; 14(3):221-9. PubMed ID: 23334791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral natural killer cell maturation depends on the transcription factor Aiolos.
    Holmes ML; Huntington ND; Thong RP; Brady J; Hayakawa Y; Andoniou CE; Fleming P; Shi W; Smyth GK; Degli-Esposti MA; Belz GT; Kallies A; Carotta S; Smyth MJ; Nutt SL
    EMBO J; 2014 Nov; 33(22):2721-34. PubMed ID: 25319415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of human natural killer cells and other innate lymphoid cells.
    Montaldo E; Vacca P; Moretta L; Mingari MC
    Semin Immunol; 2014 Apr; 26(2):107-13. PubMed ID: 24559836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of CRL4(CRBN) substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4.
    Bjorklund CC; Lu L; Kang J; Hagner PR; Havens CG; Amatangelo M; Wang M; Ren Y; Couto S; Breider M; Ning Y; Gandhi AK; Daniel TO; Chopra R; Klippel A; Thakurta AG
    Blood Cancer J; 2015 Oct; 5(10):e354. PubMed ID: 26430725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Innate lymphoid cells].
    Crinier A; Viant C; Girard-Madoux M; Vivier É
    Med Sci (Paris); 2017 May; 33(5):534-542. PubMed ID: 28612730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 1 innate lymphoid cell aggravation of atherosclerosis is mediated through TLR4.
    Wu C; He S; Liu J; Wang B; Lin J; Duan Y; Gao X; Li D
    Scand J Immunol; 2018 May; 87(5):e12661. PubMed ID: 29570822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fingolimod Alters Tissue Distribution and Cytokine Production of Human and Murine Innate Lymphoid Cells.
    Eken A; Yetkin MF; Vural A; Okus FZ; Erdem S; Azizoglu ZB; Haliloglu Y; Cakir M; Turkoglu EM; Kilic O; Kara I; Dönmez Altuntaş H; Oukka M; Kutuk MS; Mirza M; Canatan H
    Front Immunol; 2019; 10():217. PubMed ID: 30828332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activating receptor NKp65 is selectively expressed by human ILC3 and demarcates ILC3 from mature NK cells.
    Kühnel I; Vogler I; Spreu J; Bonig H; Döring C; Steinle A
    Eur J Immunol; 2024 Apr; 54(4):e2250318. PubMed ID: 38072999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of diverse innate lymphoid cells in human decidua.
    Vacca P; Montaldo E; Croxatto D; Loiacono F; Canegallo F; Venturini PL; Moretta L; Mingari MC
    Mucosal Immunol; 2015 Mar; 8(2):254-64. PubMed ID: 25052762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of aceNKPs, a committed common progenitor population of the ILC1 and NK cell continuum.
    Rodriguez-Rodriguez N; Clark PA; Gogoi M; Ferreira ACF; Kerscher B; Crisp A; Jolin HE; Murphy JE; Sivasubramaniam M; Pedro L; Walker JA; Heycock MWD; Shields JD; Barlow JL; McKenzie ANJ
    Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2203454119. PubMed ID: 36442116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma.
    Fionda C; Abruzzese MP; Zingoni A; Cecere F; Vulpis E; Peruzzi G; Soriani A; Molfetta R; Paolini R; Ricciardi MR; Petrucci MT; Santoni A; Cippitelli M
    Oncotarget; 2015 Sep; 6(27):23609-30. PubMed ID: 26269456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets.
    Robinette ML; Fuchs A; Cortez VS; Lee JS; Wang Y; Durum SK; Gilfillan S; Colonna M;
    Nat Immunol; 2015 Mar; 16(3):306-17. PubMed ID: 25621825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMiDs prime myeloma cells for daratumumab-mediated cytotoxicity through loss of Ikaros and Aiolos.
    Fedele PL; Willis SN; Liao Y; Low MS; Rautela J; Segal DH; Gong JN; Huntington ND; Shi W; Huang DCS; Grigoriadis G; Tellier J; Nutt SL
    Blood; 2018 Nov; 132(20):2166-2178. PubMed ID: 30228232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vitro model of innate lymphoid cell function and differentiation.
    Allan DS; Kirkham CL; Aguilar OA; Qu LC; Chen P; Fine JH; Serra P; Awong G; Gommerman JL; Zúñiga-Pflücker JC; Carlyle JR
    Mucosal Immunol; 2015 Mar; 8(2):340-51. PubMed ID: 25138665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Established and emergent roles for Ikaros transcription factors in lymphoid cell development and function.
    Read KA; Jones DM; Freud AG; Oestreich KJ
    Immunol Rev; 2021 Mar; 300(1):82-99. PubMed ID: 33331000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.